Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-29

Clinical Trial Update: Oral Lactobacillus Supplementation as Treatment for Overactive Bladder Syndrome: A Randomised Controlled Trial [NA]

View source ↗

Summary

A randomized controlled trial is evaluating oral Lactobacillus probiotic supplementation as a treatment for Overactive Bladder Syndrome; the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral Lactobacillus probiotic (Lactobacillus probiotic)

Snippet

Sponsor: Medical University of Vienna | Conditions: Overactive Bladder Syndrome | NA | Status: RECRUITING